Technology
Health
Medical

Provention Bio

1,115

$8.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.39 (+4.99%) As of 2:57 PM EDT today
+$0.39 (+4.99%) Today

Why Robinhood?

You can buy or sell Provention Bio and other stocks, options, ETFs, and crypto commission-free!

About PRVB

Provention Bio, Inc. Common Stock, also called Provention Bio, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Read More Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn's disease; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.

CEO
Ashleigh W. Palmer
Employees
19
Headquarters
Lebanon, New Jersey
Founded
2016
Market Cap
377.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
703.08K
High Today
$8.72
Low Today
$7.93
Open Price
$8.23
Volume
400.43K
52 Week High
$22.82
52 Week Low
$2.31

Collections

Technology
Health
Medical
Biopharmaceutical
Therapy
Pharmaceutical
2018 IPO
US

PRVB Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, Pre-Market

People Also Bought

VBI Vaccines

10,916

$0.9736

-3.60%

VBI Vaccines

10,916

$0.9736

-3.60%

Amarin

35,885

$4.81

+0.52%

La Jolla Pharmaceutical

1,240

$5.50

+6.80%

Aurinia Pharmaceuticals

11,175

$14.89

+3.19%

You May Also Like

WMB
AMSF
NMCI
SQ
IGLB
SKM
MDCA
OPRX
TTDKY
ACGLO
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy PRVB

Market Price$8.20
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Provention Bio stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up